CSF2 and neoplasm: This translated to seminal clinical findings in the prospective study by Golden et al where patients with multiple tumor types received GM‐CSF administered for 2 weeks with radiation and investigator's choice of chemotherapy where an impressive 27% abscopal response rate was noted.